Oregon Health & Science University researchers have unveiled 'thermoregulatory inversion,' successfully inducing hibernation-like states in rats by targeting the ventromedial periventricular area (VMPeA). This 2024 breakthrough promises enhanced therapeutic hypothermia for critical conditions like heart attacks and strokes, potentially boosting survival rates. Techniques include activating A1 adenosine receptors and VMPeA manipulation. With applications ranging from surgeries to space missions, OHSU is cooling their way to saving lives—one degree at a time.